Influence of ursodeoxycholic acid on hepatic lipid deposition, blood glucose, and insulin levels in high-fat -fed Sprague–Dawley rats
Journal of Clinical and Translational Research · 08.09.2026 · 12 (5) · 026090015
DOI: 10.36922/jctr026090015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical and Translational Research, online erschienen am 08.09.2026. Verfasst von Xiuping Bai und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Metabolic dysfunction-associated steatotic liver disease (MASLD) is becoming a growing public health concern. MASLD often coexists with abnormal glucose metabolism. Currently, there is no standard treatment for MASLD.
Aim
To elucidate the influence of ursodeoxycholic acid (UDCA) on hepatic lipid deposition, blood glucose, and insulin levels in high-fat diet-induced Sprague–Dawley (SD) rats.
Methods
SD rats were randomly assigned to three groups: Group A, which comprised a normal-diet control group; Group B, which comprised a high-fat-fed group; and Group C, which comprised rats treated with UDCA combined with a high-fat diet. At the end of week 4, we performed oral glucose tolerance tests, measured liver enzymes, triglyceride (TG) and total cholesterol (TC) contents, identified morphological changes of the liver, and quantified the expression of major genes in fatty acid, glucose, and bile acid metabolic pathways using real-time polymerase chain reaction.
Results
In comparison to Group A, Group B had higher postprandial glucose, insulin, C-peptide, and hepatic TG and TC concentrations (all p < 0.05); metabolism-related genes were differentially expressed in Group B. In comparison to Group B, the values of these indices were all decreased in Group C (all p < 0.05); UDCA reversed the mRNA expression of metabolism-related genes in Group C (all p < 0.05).
Conclusion
UDCA administration decreased hepatic lipid content, blood glucose, and insulin levels in SD rats. Relevance for patients: UDCA may be helpful in the treatment of MASLD and its related comorbidities in clinical practice.
Zitieren
APA
Bai, X., Han, Y., Wei, L., Han, X., & Dong, F. (2026). Influence of ursodeoxycholic acid on hepatic lipid deposition, blood glucose, and insulin levels in high-fat -fed Sprague–Dawley rats. Journal of Clinical and Translational Research, 12(5), 026090015. https://doi.org/10.36922/jctr026090015
Vancouver
Bai X, Han Y, Wei L, Han X, Dong F. Influence of ursodeoxycholic acid on hepatic lipid deposition, blood glucose, and insulin levels in high-fat -fed Sprague–Dawley rats. Journal of Clinical and Translational Research. 2026;12(5):026090015. doi:10.36922/jctr026090015
BibTeX
@article{Bai2026,
author = {Bai, Xiuping and Han, Yufeng and Wei, Lingyan and Han, Xiaojin and Dong, Feng},
title = {Influence of ursodeoxycholic acid on hepatic lipid deposition, blood glucose, and insulin levels in high-fat -fed Sprague–Dawley rats},
journal = {Journal of Clinical and Translational Research},
year = {2026},
volume = {12},
number = {5},
pages = {026090015},
doi = {10.36922/jctr026090015}
}
EUVIMED